Legislation on reforming FDA's process for adding OTC drug monograph ingredients and indications will arrive at the House Energy and Commerce Committee loaded with concerns about the two-year market exclusivity it would allow for some new products.
Support was unanimous during the Health Subcommittee's Jan. 17 markup to send to Energy and Commerce draft legislation on...